Osteoporosis medication adherence is poor

Share this article:
Adherence to osteoporosis medications is relatively poor, according to recent article in the journal Drugs & Aging. About 20% to 30% of patients taking daily or weekly treatments may suspend use within six to 12 months of initiating therapy, a study appearing in the January issue said.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions